Texas Heart Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1962-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.texasheart.org
Pomegranate Products for Prevention of Common Cold
Phase 3
Completed
- Conditions
- InfluenzaCoughFeverCommon ColdHeadache
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Pomegranate
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2008-02-18
- Lead Sponsor
- Texas Heart Institute
- Target Recruit Count
- 461
- Registration Number
- NCT00617318
- Locations
- 🇺🇸
Site 01, San Diego, California, United States
Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)
Phase 1
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Biological: Stem Cell TherapyOther: Control (plasma)
- First Posted Date
- 2006-04-13
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Texas Heart Institute
- Target Recruit Count
- 21
- Registration Number
- NCT00314366
- Locations
- 🇺🇸
Texas Heart Institute/Baylor St. Luke's Medical Center, Houston, Texas, United States
Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)
Phase 1
Completed
- Conditions
- Ischemic Cardiomyopathy
- Interventions
- Device: Intramyocardial Injection of stem cells via NOGA MappingOther: Control, then Stem Cell Therapy
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2016-11-28
- Lead Sponsor
- Texas Heart Institute
- Target Recruit Count
- 30
- Registration Number
- NCT00203203
- Locations
- 🇺🇸
Texas Heart Institute/Baylor St. Luke's Medical Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath